AstraZeneca Completes Acquisition of Fusion
AstraZeneca has completed the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).
Fusion Pharmaceuticals | 06/06/2024 | By Aishwarya | 101
AstraZeneca Acquires Fusion Pharmaceuticals to Transform Cancer Treatment
Fusion Pharmaceuticals Inc. has signed a definitive agreement to be acquired by AstraZeneca.
Fusion Pharmaceuticals | 20/03/2024 | By Manvi | 253
Fusion Pharmaceuticals opens radiopharmaceutical manufacturing facility
The 27,000 sq ft GMP-compliant facility, located adjacent to the company’s R&D labs, has clinical and commercial manufacturing scale capabilities designed to support the Company's growing pipeline of targeted alpha therapies
Fusion Pharmaceuticals | 04/05/2023 | By Sudeep Soparkar | 405
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy